PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.\', \'Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.\', \'Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.\', \'Oncology Department, Lausanne University Hospital, Lausanne, Switzerland.\', \'Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Brigham and Women\'s Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: toni_choueiri@dfci.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1535-6108(20)30217-810.1016/j.ccell.2020.04.018
?:hasPublicationType
?:journal
  • Cancer cell
is ?:pmid of
?:pmid
?:pmid
  • 32454025
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 12.7
?:rankingScore_hIndex
  • 284
?:title
  • The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all